RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTH) — FDA Approval ANDA085549
RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTH) — FDA Approval ANDA085549 is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE; Active ingredients: HYDRALAZINE HYDROCHLO
| Brand name | RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE |
| Application number | ANDA085549 |
| Sponsor | WATSON LABS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19770929 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →